Back to research

Research paper

Inflammatory markers (IL-6 and CRP) in childhood and adult brain structure

Longitudinal study linking childhood inflammatory exposure to adult brain structural differences. Supports the model that chronic childhood inflammation has measurable long-term structural consequences.

Indexed context

Merritt VC, et al.

neuroinflammationchildhood-inflammationbrain-structurelongitudinal2026

Markdown path

content/research/papers/2026-merritt-childhood-inflammation-adult-brain-structure.md

Findings

Longitudinal study linking childhood inflammatory exposure to adult brain structural differences. Supports the model that chronic childhood inflammation has measurable long-term structural consequences.

Why it may matter for Levi

Reinforces the existing neuroinflammation theory in the differential (secondary hypothesis). If Levi's Th1/Th17 signature persists untreated, the long-term structural consequences literature argues for active surveillance and, if indicated, immunomodulation. Supports existing CSF-cytokine/AE-panel/neopterin diagnostic priority.

Paper text

Merritt et al. (2026) — Childhood inflammation and adult brain structure

Source

  • Brain, Behavior, and Immunity, 2026.

Why in corpus

Longitudinal evidence that childhood inflammatory markers (IL-6, CRP) are associated with adult brain-structure differences — including reduced brain volume in key regions.

Key findings

  • IL-6 in childhood linked to reduced adult brain volume in key regions.
  • CRP less strongly but measurably associated with structural outcomes.
  • Suggests that chronic inflammation during childhood may produce lasting structural changes rather than transient effects.

Levi-relevant takeaways

  • Meaningful long-horizon concern: if Levi's current Th1/Th17-weighted cytokine signature reflects ongoing chronic neuroinflammation, the downstream structural consequences may outlast the DEE-SWAS phase itself.
  • Reinforces the priority of identifying and treating the inflammatory driver, not just suppressing the electrographic SWAS pattern.
  • Supports the case for serial quantitative measurement of Levi's inflammatory markers, not just treating the March 2026 serum draw as a single timepoint.
  • Family-facing framing: "inflammation that persists may shape brain development over years, which is why the immune-inflammatory axis is a separate treatment priority from the seizure axis."